Market Overview:
The global coccidiostat market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for meat and poultry products, rising awareness about animal health, and growing concerns about zoonotic diseases. In terms of type, the nonantibiotic segment is expected to grow at a higher CAGR than the antibiotic segment during the forecast period. This can be attributed to the increasing preference for organic food products and growing concerns about antibiotic resistance. By application, cattle is projected to be the fastest-growing segment during the forecast period. This can be attributed to rising demand for beef and veal products in developed countries such as Europe and North America.
Product Definition:
A coccidiostat is a medication used to treat or prevent coccidiosis, an infection caused by the parasite Eimeria. Coccidiosis most commonly affects poultry, but can also affect other animals such as pigs and cattle. The most common symptom of coccidiosis is diarrhea, which can lead to dehydration and death if left untreated. Coccidiostats are used to prevent and treat this infection in livestock.
Nonantibiotic:
Nonantibiotic is a new term in the market and it means any drug or medication which has no antibacterial activity. The most common types of nonantibiotics are cephalosporin, penicillin, tetracycline, macrolides and quinolones. Cephalosporin is widely used as antibiotics but it has many side effects associated with it such as kidney damage & blindness.
Antibiotic:
Antibiotics are used to treat bacterial infections. Some of the common types of bacterial infections that antibiotics are used for include ear infection, bronchitis, pneumonia, and urinary tract infection. Antibiotics can also be used in wound healing and to prevent certain diseases such as rheumatoid arthritis. However, excessive use of antibiotics can lead to drug resistance which further requires stronger doses for treatment resulting in increased side effects and costlier treatment options available today.
Application Insights:
Coccidiostat is used in the treatment of coccidiosis, which is a major disease affecting animals. The disease results in reduced weight gains and production losses for livestock. Coccidiostat-based products are available for animal usage in various forms including tablets, granules, and liquid concentrate for oral administration to animals.
The global market has witnessed significant growth due to rise in pet ownership across the globe. According to an article published by the Pet Industry Joint Advisory Council (PIJAC), there were 78 million pet dogs worldwide as of 2016 with an estimated value of USD 44 billion; this number was increased by around 11% from 2015. Similarly, there were 63 million cats kept as pets across U.S., with a total value of USD 26 billion; this number was increased by 10% from 2015).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to rising awareness among people about coccidiosis and its treatment, availability of efficient drugs, high disease incidence rate, and presence of well-established animal health organizations that provide information regarding diseases prevalent in various livestock animals.
Asia Pacific is anticipated to witness a lucrative growth rate over the forecast period owing to increasing focus of governments on improving animal health standards through organized efforts such as “Swine Health Protection Scheme†implemented by India in 2013 and other similar initiatives taken by various governments across countries including China & Australia for poultry & cattle animals respectively are estimated to boost regional demand for coccidiostats during the forecast period.
Growth Factors:
- Increasing awareness about coccidiostats and their benefits in animal husbandry is expected to drive the market growth.
- Rising demand for meat and poultry products, especially in developing countries is anticipated to boost the demand for coccidiostats over the forecast period.
- Growing research and development activities for new coccidiostat products is likely to create opportunities for market players.
- Stringent regulations by government agencies regarding use of coccidiostats in animal husbandry is projected to hamper the growth of this market during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Coccidiostat Market Research Report
By Type
Nonantibiotic, Antibiotic
By Application
Cattle, Sheep, Pigs, Cats and Dogs, Poultry
By Companies
Zoetis, Bayer Healthcare Animal Healthcare, Merck Animal Healthcare, Elanco, Vitafor, Rabar Animal Nutrition, Huvepharma, Ceva, Zoetis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Coccidiostat Market Report Segments:
The global Coccidiostat market is segmented on the basis of:
Types
Nonantibiotic, Antibiotic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cattle, Sheep, Pigs, Cats and Dogs, Poultry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Bayer Healthcare Animal Healthcare
- Merck Animal Healthcare
- Elanco
- Vitafor
- Rabar Animal Nutrition
- Huvepharma
- Ceva
- Zoetis
Highlights of The Coccidiostat Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nonantibiotic
- Antibiotic
- By Application:
- Cattle
- Sheep
- Pigs
- Cats and Dogs
- Poultry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Coccidiostat Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Coccidiostat is a medication used to treat coccidioidomycosis, a fungal infection of the lungs. It works by stopping the growth of the fungus.
Some of the major players in the coccidiostat market are Zoetis, Bayer Healthcare Animal Healthcare, Merck Animal Healthcare, Elanco, Vitafor, Rabar Animal Nutrition, Huvepharma, Ceva, Zoetis.
The coccidiostat market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Coccidiostat Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Coccidiostat Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Coccidiostat Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Coccidiostat Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Coccidiostat Market Size & Forecast, 2020-2028 4.5.1 Coccidiostat Market Size and Y-o-Y Growth 4.5.2 Coccidiostat Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Nonantibiotic
5.2.2 Antibiotic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cattle
6.2.2 Sheep
6.2.3 Pigs
6.2.4 Cats and Dogs
6.2.5 Poultry
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Coccidiostat Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Coccidiostat Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Nonantibiotic
9.6.2 Antibiotic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cattle
9.10.2 Sheep
9.10.3 Pigs
9.10.4 Cats and Dogs
9.10.5 Poultry
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Nonantibiotic
10.6.2 Antibiotic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cattle
10.10.2 Sheep
10.10.3 Pigs
10.10.4 Cats and Dogs
10.10.5 Poultry
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Nonantibiotic
11.6.2 Antibiotic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cattle
11.10.2 Sheep
11.10.3 Pigs
11.10.4 Cats and Dogs
11.10.5 Poultry
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Nonantibiotic
12.6.2 Antibiotic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cattle
12.10.2 Sheep
12.10.3 Pigs
12.10.4 Cats and Dogs
12.10.5 Poultry
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Nonantibiotic
13.6.2 Antibiotic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cattle
13.10.2 Sheep
13.10.3 Pigs
13.10.4 Cats and Dogs
13.10.5 Poultry
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Coccidiostat Market: Competitive Dashboard
14.2 Global Coccidiostat Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Bayer Healthcare Animal Healthcare
14.3.3 Merck Animal Healthcare
14.3.4 Elanco
14.3.5 Vitafor
14.3.6 Rabar Animal Nutrition
14.3.7 Huvepharma
14.3.8 Ceva
14.3.9 Zoetis